Aptamers are oligonucleotides or peptides that bind to a specific target molecule. Aptamers are useful in biotechnological and therapeutic applications as they offer molecular recognition properties that rival that of the commonly used biomolecule, antibodies. In addition to their discriminate recognition, aptamers offer advantages over antibodies as they can be engineered completely in a test […]
ST. LOUIS, Sigma-Aldrich Corporation (Nasdaq: SIAL) was named today for the first time to the “Global 100 Most Sustainable Corporations in the World” list in an announcement made earlier at the World Economic Forum in Davos, Switzerland. The St. Louis-based Company was ranked 20th, one of the highest rankings among its peers. “We are excited […]
Kalen Biomedical, LLC (https://www.kalenbiomed.com) is pleased to announce a distribution agreement with MRTeck Co. in South Korea. Montgomery Village, MD. Kalen Biomedical, LLC has signed a distribution agreement with MRTeck Co. to offer premium lipoproteins to researchers in Korea. Kathy K. Foxx, President of Kalen Biomedical said, “We have a long relationship with MRTeck and […]
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of its new Next Generation Sequencing services for microRNAs and other RNAs. Exiqon’s Next Generation Sequencing services provide a complete sample-to-answer solution including biological interpretation of customer’s results. Results are delivered within 4-6 weeks of sample submission. […]
Cambridge UK,Abcam plc., a global leader in the supply of innovative protein research tools, has announced that it will open a new office in February 2014, in Shanghai, China. The new hub is the Company’s ninth global office, and has been established to support Abcam’s focus on increasing geographic reach and improving distribution channels to […]
ACM Biolabs, a spin-off company from A*STAR’s Institute of Materials Research and Engineering (IMRE), will market novel plastic cell membranes to be used as low-cost, easily maintained drug targets that help shorten the drug discovery process. What usually takes weeks or even months can now be done in a matter of days using these new […]
MALVERN, Pa. and CODOLET, France.– Reaction Biology Corporation (“RBC”), a leading contract research organization providing early stage drug discovery services, announced that it has signed an agreement for Cisbio Bioassays, a cutting-edge biotechnology company in the field of products and services for human in vitro diagnostics and pharmaceutical research, to distribute its epigenetic proteins. RBC […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that Sigma Life Science, its innovative biological products and services business, will be launching the genetically-modified HepaRG human liver cell line, licensed from Biopredic, for hepatotoxicity and drug metabolism assays. Currently undergoing beta-testing by multiple contract research and pharmaceutical organizations, the assays will be publicly available […]
IntelliCyt Corporation Announces First Reagent System for Multiplexed Screening of Secreted Proteins
Albuquerque, NM — IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced the MultiCyt™ QBeads™ PlexScreen family of reagents. It is the first commercially available product to enable multiplexed analysis of secreted proteins at the pace and price needed for screening and the […]
PARIS — Cellectis (Paris:ALCLS): Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies. Under the joint offering, clients will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
